Cargando…
Use of Testing for West Nile Virus and Other Arboviruses
In the United States, the most commonly diagnosed arboviral disease is West Nile virus (WNV) infection. Diagnosis is made by detecting WNV IgG or viral genomic sequences in serum or cerebrospinal fluid. To determine frequency of this testing in WNV-endemic areas, we examined the proportion of tests...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994361/ https://www.ncbi.nlm.nih.gov/pubmed/27537988 http://dx.doi.org/10.3201/eid2209.152050 |
_version_ | 1782449315013197824 |
---|---|
author | Vanichanan, Jakapat Salazar, Lucrecia Wootton, Susan H. Aguilera, Elizabeth Garcia, Melissa N. Murray, Kristy O. Hasbun, Rodrigo |
author_facet | Vanichanan, Jakapat Salazar, Lucrecia Wootton, Susan H. Aguilera, Elizabeth Garcia, Melissa N. Murray, Kristy O. Hasbun, Rodrigo |
author_sort | Vanichanan, Jakapat |
collection | PubMed |
description | In the United States, the most commonly diagnosed arboviral disease is West Nile virus (WNV) infection. Diagnosis is made by detecting WNV IgG or viral genomic sequences in serum or cerebrospinal fluid. To determine frequency of this testing in WNV-endemic areas, we examined the proportion of tests ordered for patients with meningitis and encephalitis at 9 hospitals in Houston, Texas, USA. We identified 751 patients (567 adults, 184 children), among whom 390 (52%) experienced illness onset during WNV season (June–October). WNV testing was ordered for 281 (37%) of the 751; results indicated acute infection for 32 (11%). Characteristics associated with WNV testing were acute focal neurologic deficits; older age; magnetic resonance imaging; empirically prescribed antiviral therapy; worse clinical outcomes: and concomitant testing for mycobacterial, fungal, or other viral infections. Testing for WNV is underutilized, and testing of patients with more severe disease raises the possibility of diagnostic bias in epidemiologic studies. |
format | Online Article Text |
id | pubmed-4994361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-49943612016-09-08 Use of Testing for West Nile Virus and Other Arboviruses Vanichanan, Jakapat Salazar, Lucrecia Wootton, Susan H. Aguilera, Elizabeth Garcia, Melissa N. Murray, Kristy O. Hasbun, Rodrigo Emerg Infect Dis Research In the United States, the most commonly diagnosed arboviral disease is West Nile virus (WNV) infection. Diagnosis is made by detecting WNV IgG or viral genomic sequences in serum or cerebrospinal fluid. To determine frequency of this testing in WNV-endemic areas, we examined the proportion of tests ordered for patients with meningitis and encephalitis at 9 hospitals in Houston, Texas, USA. We identified 751 patients (567 adults, 184 children), among whom 390 (52%) experienced illness onset during WNV season (June–October). WNV testing was ordered for 281 (37%) of the 751; results indicated acute infection for 32 (11%). Characteristics associated with WNV testing were acute focal neurologic deficits; older age; magnetic resonance imaging; empirically prescribed antiviral therapy; worse clinical outcomes: and concomitant testing for mycobacterial, fungal, or other viral infections. Testing for WNV is underutilized, and testing of patients with more severe disease raises the possibility of diagnostic bias in epidemiologic studies. Centers for Disease Control and Prevention 2016-09 /pmc/articles/PMC4994361/ /pubmed/27537988 http://dx.doi.org/10.3201/eid2209.152050 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Vanichanan, Jakapat Salazar, Lucrecia Wootton, Susan H. Aguilera, Elizabeth Garcia, Melissa N. Murray, Kristy O. Hasbun, Rodrigo Use of Testing for West Nile Virus and Other Arboviruses |
title | Use of Testing for West Nile Virus and Other Arboviruses |
title_full | Use of Testing for West Nile Virus and Other Arboviruses |
title_fullStr | Use of Testing for West Nile Virus and Other Arboviruses |
title_full_unstemmed | Use of Testing for West Nile Virus and Other Arboviruses |
title_short | Use of Testing for West Nile Virus and Other Arboviruses |
title_sort | use of testing for west nile virus and other arboviruses |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994361/ https://www.ncbi.nlm.nih.gov/pubmed/27537988 http://dx.doi.org/10.3201/eid2209.152050 |
work_keys_str_mv | AT vanichananjakapat useoftestingforwestnilevirusandotherarboviruses AT salazarlucrecia useoftestingforwestnilevirusandotherarboviruses AT woottonsusanh useoftestingforwestnilevirusandotherarboviruses AT aguileraelizabeth useoftestingforwestnilevirusandotherarboviruses AT garciamelissan useoftestingforwestnilevirusandotherarboviruses AT murraykristyo useoftestingforwestnilevirusandotherarboviruses AT hasbunrodrigo useoftestingforwestnilevirusandotherarboviruses |